The National Assembly was informed on Friday that Pakistan is facing a shortage of Apidra, a rapid-acting insulin manufactured by Sanofi, following a disruption at its German production facility. Parliamentary Secretary for Health Nelson Azeem said supplies had fallen from 3, 500 kits to 1, 000, with the manufacturing upgrade expected to take a year. His assurance
Read full story on Daily Times – Latest Pakistan News, World, Busines
GrowthPakistan brings you the latest news to keep an eye on Pakistan’s startup ecosystem. Business keeps you growing when you stay aware of your competitors' moves. GrowthPakistan offers Business, Tech, Global Tech, Global, Auto, and Startup News straight from industries all around the globe. This platform will help you identify upcoming opportunities not only in Pakistan but worldwide.
Email : growthpakistan@gmail.com
Whatsapp : +92320-9497079
© growthpakistan
